NSE · BSE · Real-time

Breaking Corporate Events, Analysed in Real Time

High-value corporate events — new orders, fund raises, capacity expansions, and earning calls — analysed by AI the moment they hit the exchange.

All New Order Fund Raise Expansion Earning Call Regulatory Approval Production Started Product Launched
Tagged Generics
Aurobindo Pharma Subsidiary Lannett Launches First US Inhalation Product in $908M Market
Product Launched

Aurobindo Pharma Subsidiary Lannett Launches First US Inhalation Product in $908M Market

Aurobindo Pharma's subsidiary, Lannett Company LLC, has commercialised a generic version of Advair Diskus in the United States. This represents the company's entry into the complex US inhalation market, targeting a therapeutic area valued at nearly $1 billion.

Aurobindo Pharma Ltd (524804)
31 Aug 2026 4 min read
Lupin Launches Sugammadex Injection in US Following FDA Approval for Bridion Generic
Product Launched

Lupin Launches Sugammadex Injection in US Following FDA Approval for Bridion Generic

Lupin Limited has announced the commercial launch of Sugammadex Injection in the United States following approval from the U.S. FDA. The product, a generic version of Merck's Bridion®, serves as a critical agent for reversing neuromuscular blockade in surgical patients.

Lupin Limited
31 Jul 2026 4 min read